|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net income | |||||
| Reconciliation of net income to net cash flow provided by operating activities: | |||||
| Depreciation and accretion | |||||
| Amortization of intangible assets | |||||
| Amortization of major maintenance costs for reaction-based plants | |||||
| Other amortization expense | |||||
| Impairment of assets other than goodwill (see Notes 2 and 4) | |||||
| Equity in income of unconsolidated affiliates | |||||
| Distributions received from unconsolidated affiliates attributable to earnings | |||||
| Net losses (gains) attributable to asset sales and related matters | |||||
| Deferred income tax expense | |||||
| Change in fair market value of derivative instruments | |||||
| Non-cash expense related to long-term operating leases (see Note 17) | |||||
| Net effect of changes in operating accounts (see Note 19) | |||||
| Other operating activities | |||||
| Net cash flow provided by operating activities | |||||
| Investing activities: | |||||
| Capital expenditures | |||||
| Cash used for business combinations, net of cash received (see Note 12) | |||||
| Investments in unconsolidated affiliates | |||||
| Distributions received from unconsolidated affiliates attributable to the return of capital | |||||
| Proceeds from asset sales and other matters | |||||
| Other investing activities | |||||
| Net cash flow used in investing activities | |||||
| Financing activities: | |||||
| Borrowings under debt agreements | |||||
| Repayments of debt | |||||
| Debt issuance costs | |||||
| Monetization of interest rate derivative instruments (see Note 14) | |||||
| Cash distributions paid to common unitholders (see Note 8) | |||||
| Cash payments made in connection with distribution equivalent rights | |||||
| Cash distributions paid to noncontrolling interests (see Note 8) | |||||
| Cash contributions from noncontrolling interests (see Note 8) | |||||
| Repurchase of common units under 2019 Buyback Program (see Note 8) | |||||
| Other financing activities | |||||
| Net cash flow used in financing activities | |||||
| Net change in cash and cash equivalents, including restricted cash | |||||
| Cash and cash equivalents, including restricted cash, January 1 | |||||
| Cash and cash equivalents, including restricted cash, December 31 | |||||
Loading...